1. Dephenylation of N-phenyl-2-naphthylamine in dogs and its possible oncogenic implications
- Author
-
P L Batten and D E Hathway
- Subjects
Male ,Urinary output ,Cancer Research ,medicine.medical_specialty ,Aniline Compounds ,Time Factors ,2-Naphthylamine ,Urinary system ,Neoplasms, Experimental ,Urine ,Metabolism ,Naphthalenes ,Biology ,chemistry.chemical_compound ,Dogs ,Endocrinology ,Oncology ,chemistry ,Internal medicine ,medicine ,Animals ,Female ,Carcinogen ,Research Article - Abstract
N-Dephenylation of N-phenyl-2-naphthylamine (PBNA) is strictly limited in dogs, and a 5 mg/kg dose gives 0-10 microng of urinary 2-naphthylamine (BNA), which does not appear to undergo further metabolism. Neither 2-naphthylhydroxylamine (BNHA) nor 2-amino-1-naphthylsulphate were detected in the urine of treated animals. Urinary output of BNA varies markedly between dogs, and at different times in the same animal. The extent of PBNA N-dephenylation is unaltered by chronic administration. Calculations based on Druckery and Küpfmüller's equation (1948) and present data indicate that, for dogs to form BNA tumours through exposure to a relatively high dose-level of PBNA, the period of daily dosing would occupy, or even exceed, the normal life-span. The carcinogenic risk of PBNA to human subjects is discussed.
- Published
- 1977